# Step 129 — PC07.01 / DE09.026 prescription status evidence correlation

2026-10-21. **DE09.026 — SATISFIED — VERIFIED (native-prescription scope and recorded qualifications). PC07.01 remains PARTIAL. Inventory before/after: 10 mandatory-gap IDs / three packages.**

## Checkpoint and boundary

Read AGENTS.md and latest relevant [Step 128](195-step128-de09-023-prescription-identifier-evidence-correlation.md) findings first. Branch `main`; HEAD `6fd2c8f017db46a97b3a0cf5dd67ece72c8b647a`. Existing tracked AGENTS.md/telemetry/middleware/test changes and untracked reports 168–195 and request-correlation implementation/tests preserved. Proposed filename availability checked. Only this report is added.

Read-only targeted specification/report/source/historical-result inspection; no SQL connection, clinical request, fixture/manual test, automated test execution, build, permission change, restart, staging, commit or push. Prior [DE09.019 closure and correction disposition](194-step127rk-de09-019-evidence-closure-pc07-01-reconciliation.md) and DE09.023 closure remain unchanged with their qualifications. Nothing is modified in either prescription.

## Authoritative definition and terminology

Direct read-only ZIP/XML inspection of the existing local [CDS-S Data Dictionary v2.1 Final](</D:/MasterProgram_Ahmed/Ontario EMR Specification/Foundation/emr core data set standard (cds-s) - 5.2 dfu - 2026-07-10/EMR Core Data Set Standard (CDS-S) - Data Dictionary (v2.1).xlsx>), `Data Dictionary!A152:K152`, `Legend!A3:B7`, `Code Tables!A702:F709`. Version/publication and Baseline/CDS-S context are retained from [Step 115 section 2](150-step115-pc07-01-medication-de09-requirement-resolution.md) and Step 128: workbook 2.1 Final, publication 2026-06-05; Baseline document 1.7 section 2.7 PC07.01(f)/PC07.06; CDS-S Requirements 1.1 Final CDS01.01/.02. No new PDF or external-source reading claimed.

| Source | Direct requirement |
|---|---|
| A152/D152 | DE09.026 — Prescription Status |
| E152 | “Describes the lifecycle of the prescription (e.g., new, active, suspended).” |
| C152/F152 | **M / S**: mandatory support, store-only |
| G152/H152 | CT-035: Prescription Status / **Optional** |
| K152 | Medication logical model entity |
| Legend B7 | Optional means the offering may or may not support the code set |

CT-035 lists **New, Active, Suspended, Aborted, Completed, Obsolete, Nullified** (rows 703–709). These are optional vocabulary entries, not mandatory implemented states or required transitions. The field itself remains mandatory. The definition's examples do not override H152 Optional or prescribe a complete transition graph. This row/legend specifies no cardinality, physical data type, required exchange/reporting format, mandatory status label on PDF/CPP, or particular external dispense-state model.

MicroEMR retains its local vocabulary; this review does **not** declare Draft=New, Finalized=Active, Cancelled=Aborted or Superseded=Obsolete. CT-035 adoption or an external status conversion would need a separately approved semantic/exchange contract. The current decision concerns stored native prescription lifecycle support, not CT-035 conformance.

## Local status mapping and transitions

[Migration 0050](../../db/tenant-clinical/migrations/0050-patient-prescription-foundation.sql) defines non-null `PatientPrescription.Status nvarchar(20)`, default Draft and a CHECK restricting values to Draft/Finalized/Cancelled/Superseded. [Application constants/DTO/service](../../src/MicroEMR.Application/PatientPrescriptions/PatientPrescriptionModels.cs) expose the same values and return Status on retrieval/lifecycle responses. [Repository](../../src/MicroEMR.Infrastructure/PatientPrescriptions/PatientPrescriptionRepository.cs) maps the stored Status and uses patient/resource parameters; it does not derive prescription status from medication-list classifications.

| Local value | Existing prescription meaning / transition | Evidence type |
|---|---|---|
| Draft | Persisted mutable order, including a new correction Draft; creation does not supersede its source | Schema/current 0085 CreateDraft, prior deployed metadata and historical tests |
| Finalized | Existing Draft finalized by its owning prescriber with current version/provider; signing path also requires explicit signature intent and stores one frozen artifact | 0074 signing and 0084 effective finalization definitions; prior deployed audit/metadata and tests |
| Cancelled | Existing Finalized prescription cancelled by original prescriber with reviewed version; timestamps/actor/reason recorded, original artifact retained | 0084 Cancel definition and historical real HTTP/SQL tests |
| Superseded | Original Finalized prescription becomes superseded only when its correction is finalized; source/new record links retained | 0074/0084 transaction and historical correction tests |

[0085](../../db/tenant-clinical/migrations/0085-private-prescription-notes.sql) retains active-actor/provider and same-patient Finalized-source checks for correction creation. [0084](../../db/tenant-clinical/migrations/0084-prescription-generic-name.sql) finalization/cancellation and [0074 signing](../../db/tenant-clinical/migrations/0074-prescription-print-signing.sql) guard lifecycle writes by existing patient/owner/state/version, transact audit/artifact changes and roll back on failed transitions. These are static implementation observations, not Step 129 runtime tests or a claim to have enumerated every possible concurrency path.

Prescription cancellation is not medication-plan discontinuation, treatment completion, patient adherence, dispensing, or external pharmacy cancellation. Ongoing/Acute classification and DE09.016/.025 treatment semantics remain separate; DE09.017 past-medication mapping is not closed here. A finalized order does not prove current therapy, actual dispense or successful external transmission. No Suspended/Completed clinical behavior is inferred from the local values.

## Existing verification evidence

### Recorded development lifecycle

Reuse [R-I](192-step127ri-pc07-01-final-evidence-completion.md), [R-J](193-step127rj-pc07-01-prescription-count-reconciliation.md) and [R-K](194-step127rk-de09-019-evidence-closure-pc07-01-reconciliation.md):

- Original `f8ccb7b2-7462-4f18-9ddd-cfddd3f234d8` was Draft and then Finalized by user 2; audit **861**, one artifact and unchanged post-finalization version/hash/revision metadata. No new finalization is performed.
- Correction `ffd80110-e565-46de-b660-3d3f9dc7e463` remains Draft, created by user 2 with audit **881** and SupersedesPrescriptionUid pointing to the original. The owner intentionally invoked Correction; original remains Finalized, rather than prematurely Superseded. These exact selected records have **not** been cancelled or used to verify live supersession.
- Prior database identity checks establish `MicroEMR_LocalDev_Fresh`, TenantUid `F94C6ECD-4417-483E-8A94-0507CF8384C2`. That is recorded development evidence, not a fresh query or proof for all deployments.

### Historical execution, independently of current source

Read selected existing results in `artifacts/step118/step118-final-relevant.trx`, whose gate is recorded in [Step 118](153-step118-pc07-01-prescription-generic-name-implementation.md), without running anything:

- `RealHttpRoundTripEditSignCorrectionAndCancelKeepRecordedPrecision`: **Passed** for Day/Month/Year cases. Existing test source performs real HTTP create/edit/sign/correct/sign/cancel, checks original Superseded status and immutable artifacts, and rejects editing a finalized source. It supports native transition/retrieval behavior; it is not a separate manual selected-fixture cancellation.
- `SignedCorrectionCopiesNewFieldsButRequiresItsOwnSignatureAndPreservesSource`: **Passed**. Explicitly checks new correction Status Draft, no finalization/artifact until separately signed, source Status Superseded after correction signing and one supersession audit.
- `FutureSnapshotCorrectionAndLifecycleAuditPreserveOriginalArtifact`: **Passed** for finalize and sign-and-finalize variants; checks retained original artifact and existing finalization/supersession audit snapshots.
- `SigningRequiresIntentCurrentOwnerProviderAndVersion` and `RealHttpPermissionsBothTenantDirectionsOwnershipActorAndInvalidInputAreRejected`: **Passed**; reused owner/provider/version and permission/patient/tenant boundary evidence.

Also read the specific Passed result in `artifacts/step121/step121-final-relevant.trx` for `DraftCancellationRejectedFinalizedCancellationRetainsProtectedContentAndArtifact`. [Step 121](156-step121-pc07-01-private-prescription-notes-implementation.md) records that historical final gate. The existing test explicitly asserts cancellation of a Draft is rejected without version change, another prescriber's cancellation is rejected, the owning prescriber's finalized cancellation returns **Cancelled**, finalized editing stays rejected, and private revision/artifact retention remains intact. No protected note text is retrieved by Step 129. Historical test data/isolated SQL deployment is distinct from the selected development fixture and production.

No test totals are combined or represented as a new Step 129 run. Current source inspection explains assertions; prior Passed outcomes, not source presence alone, supply the automated execution evidence.

## API/UI/output, authorization and audit

[API](../../src/MicroEMR.Api/Controllers/PatientPrescriptionsController.cs) returns the stored DTO Status on create/get/update/finalize/cancel/correction. GET verifies patient/resource correspondence. Existing Patients.View, Prescriptions.Prescribe, trusted clinical actor and tenant database resolution remain; lower layers enforce active provider/owner/state/version where applicable. Historical both-tenant/wrong-patient tests and selected tenant metadata are reused, not a new universal security verification.

[Details view](../../src/MicroEMR.Web/Views/PatientPrescriptions/Detail.cshtml) displays Status as a badge; the [patient prescription list](../../src/MicroEMR.Web/Views/Patients/Details.cshtml) displays it and presents edit/sign for Draft and correction/cancel for Finalized. This is static UI evidence plus previous owner-reported finalized/read-only observations; there is no new visual verification of Cancelled/Superseded badges. [CPP projection](../../src/MicroEMR.Application/PatientCpp/PatientCppService.cs) includes Finalized prescription rows only. That filter is not a reconciled active medication plan or proof of ongoing treatment. F152=S requires no additional status display on Details/card/PDF/CPP, and this review invents no export mapping or output test.

Existing audit names are PrescriptionDraftCreated, PrescriptionFinalized, PrescriptionCancelled and PrescriptionSuperseded. Selected fixture audits 737/861/881 are retained in prior reports; historical tests cover cancellation/supersession and transactional behavior. Some selected events have NULL enrichment/request correlation; bounded actor/resource/time linkage is preserved, not promoted to independent browser-trace proof. No new identifier/status-specific audit event is required by row 152 and none is generated here.

## Mandatory assertion matrix

| Authoritative assertion / supporting obligation | Implementation location | Existing verification | Result | Qualification |
|---|---|---|---|---|
| Mandatory stored prescription lifecycle element | Status column/check, DTO/repository | Selected Draft/Finalized SQL evidence; historical lifecycle HTTP/SQL results | PASS | Native prescription scope |
| State describes the prescription lifecycle | Defined Draft/Finalized/Cancelled/Superseded transitions | Recorded finalization/correction plus historical cancellation/supersession outcomes | PASS | No claim of CT-035 equivalence or external dispense status |
| Optional terminology correctly treated | H152 and Legend B7 | Direct authoritative reading | PASS | CT-035 not adopted; its seven values are not mandated states |
| Persist/retrieve lifecycle changes, with existing application guards | Scoped SQL/controller/repository and transaction/audit paths | Existing Passed transition/isolation tests and R-I/J metadata | PASS | Source inspection alone is not runtime evidence |
| Correction preserves original until finalized | Linked distinct Draft and guarded supersession | R-J/K original Finalized/new Draft; historical signed correction tests | PASS | Selected correction not finalized or altered |
| Cancellation and supersession retain historical records/artifacts | 0074/0084 | Historical explicit status/retention assertions | PASS | No live selected-patient cancellation/supersession claimed |
| Status-specific display/exchange/cardinality/transition graph mandated by DE09.026 | Row 152/Legend inspected | No additional such requirement specified | PASS for requirement reconciliation | No new mandatory behavior inferred; separate integration requirements not waived |

## Closure, qualifications and inventory

**DE09.026 — SATISFIED — VERIFIED**, for stored native prescription lifecycle support, with the distinctions above. The decision combines direct authoritative definition/optional vocabulary, static persistence/API contracts, recorded development Draft/Finalized/correction behavior and existing executed cancellation/supersession tests. It does not rest solely on the presence of a Status property.

Retain source/release applicability (Baseline 1.7 in folder 5.5 versus CDS-S workbook 2.1 in folder 5.2), general deployment/identity/external-source qualifications, historical test timing, owner-reported versus independently queried evidence and bounded audit correlation. No clinical state outside the implemented local lifecycle is invented. Native status support does not settle external/legacy medication source equivalence or a future exchange contract. No mandatory field-level assertion remains unresolved within this reviewed scope; no new test/query is needed for this closure.

DE09.026 is a subordinate data element, not one of the ten top-level mandatory-gap IDs. **Before: 10 IDs / three packages. After: 10 IDs / three packages.** Prescribing PC04.01/.06/.07/.09/.14 (5); CPP PC07.01/.04/.07/.10 (4); scheduling PC09.03 (1). No entire inventory ID is closed or inventory file edited. **PC07.01 remains PARTIAL.** DE09.019/.023 closures and all other requirement statuses remain as previously recorded. Remaining evidence-only typed-name/native prescriber correlations and implementation/policy gaps, immunization amount/unit, family deployment, allergy semantics and release qualifications remain in R-K/Step 128.

**Proposed Step 130 — DE09.003 Prescription Brand/Trade Name Evidence Correlation.** Resolve the next small evidence-only mapping row retained in Step 115/117: read its exact definition and distinguish typed product/brand name from generic name, drug description and DIN; correlate existing DTO/storage/HTTP/artifact evidence without new data or tests. Preserve unknown/uncoded-source and legacy applicability; do not silently close DE09.004/.005 or implement a catalogue. Step 130 is a recommendation, not performed here.

Checks: relevant reports and direct workbook row/legend/code-table reading; targeted schema/DTO/API/UI/CPP and test-source ranges; selected historical TRX outcomes; Git/path and documentation links/whitespace/change scope. No runtime execution or clinical changes. Stop after documentation.
